New England Capital Financial Advisors LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1964652 MERIDEN, CT

Position in GILD

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$49,272

-$4,942 QoQ

Shares Held

390

+0.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#813

of 913 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

New England Capital Financial Advisors LLC holds $1,698,786 across 11 Drug Manufacturers - General names. GILD ranks #7 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	2,860	$726,354
2	MRK	Merck & Co., Inc.	2,193	$281,800
3	BMY	Bristol Myers Squibb Co	4,319	$248,860
4	PFE	Pfizer Inc	5,713	$137,569
5	AZN	Astrazeneca PLC	560	$106,187
6	ABBV	AbbVie Inc.	363	$91,345
7	GILD	Gilead Sciences, Inc. This page	390	$49,272
8	LLY	ELI LILLY & Co	34	$40,780

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$49,272	390	+0.3%	Shares	Sole	2026-07-27
2026-03-31	$54,214	389	-20.9%	Shares	Sole	2026-04-27
2025-12-31	$60,388	492	+0.2%	Shares	Sole	2026-02-02
2025-09-30	$54,501	491	+0.2%	Shares	Sole	2025-10-22
2025-06-30	$54,326	490	+0.4%	Shares	Sole	2025-08-08
2025-03-31	$54,680	488	-22.2%	Shares	Sole	2025-05-05
2024-12-31	$57,915	627	-7.0%	Shares	Sole	2025-02-04
2024-09-30	$56,508	674	+0.6%	Shares	Sole	2024-10-30
2024-06-30	$45,968	670	+0.6%	Shares	Sole	2024-07-29
2024-03-31	$48,784	666	+0.5%	Shares	Sole	2024-05-02
2023-12-31	$53,709	663	+0.6%	Shares	Sole	2024-02-01
2023-09-30	$49,385	659	+0.5%	Shares	Sole	2023-11-06
2023-06-30	$50,557	656	+0.6%	Shares	Sole	2023-08-02
2023-03-31	$54,096	652	+0.5%	Shares	Sole	2023-05-04
2022-12-31	$55,716	649	—	Shares	Sole	2023-02-06
No filing history on record for this holder in this stock.